Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Medicalsystem Biotechnology Co., Ltd.
300439.SZ
-
CNE100001Z25
Compare
Last update : Aug 25, 2026 at 23:36
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Medicalsystem Biotechnology Co., Ltd. (300439.SZ) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
4
JIJI7
Metrics
Value
Rating
Payout ratio
1
70bjb
AcNVN
Free cash flow payout ratio
33
NkxVy
PCUy4
3Y Earnings growth
100
PoZ4G
0AJya
Dividend streak
3
x23Kd
ClVc1
Dividend growth streak
73
LEmlI
2kS6d
15Y Dividend cut
94
EphKa
Ha5GN
15Y Dividend interruption
86
mYRE6
IDMCB
Return on equity
1
yZFRS
fn6MS
Net debt / EBITDA
70
qqFmL
5Gs1a
Interest coverage
51
TY9ri
TTBoq
Growth
Last update : Jul 30, 2026
6
bJY
Metrics
Value
Rating
Revenue growth
13
vpr8I
fIeJn
5Y Revenue growth
53
LGKkb
Fmtoh
EBITDA growth
92
CIniy
Financial Strength
Last update : Jul 30, 2026
14
3M6G3kp3
Metrics
Value
Rating
Interest coverage
19
TViNU
U5C3V
Quick ratio
89
HkGd3
yf2n6
Debt / Assets
38
pAZZf
Profitability
Last update : Jul 30, 2026
19
P3kbUyRA
Metrics
Value
Rating
Gross margin
60
K4qAJ
5WlOv
Operating margin
55
rMCCJ
vWRmD
Net margin
89
F9udp
bdJtI
Momentum
Last update : Aug 23, 2026
11
F3MNKdnh
Metrics
ESG
No data available currently
Piotroski F
Last update : Aug 4, 2026
7
Unlock this feature
0
3
6
9
Altman Z
Last update : Aug 4, 2026
1
Unlock this feature
0 and -
1.8
3
4.5 and +
7YBkw
5Y EBITDA growth
16
iulG0
1PZHB
Operating income growth
55
omzMR
Ii1f1
5Y Operating income growth
1
R3idI
eKX2e
Free cash flow growth
99
Db4BS
12lOz
5Y Free cash flow growth
53
WR28s
h716p
Operating cash flow growth
67
31DU0
3smrM
5Y Operating cash flow growth
48
r4k7m
wEHkP
Capex growth
17
DvmMW
p8ogg
B0oU5
Debt / Equity
28
6YQnT
P3HvB
Net debt / EBITDA
1
psIrk
24RTz
Cash / Debt
49
opU4V
HxyBU
Altman Z Score
74
wXzzF
tLVcZ
Piotroski F Score
41
tTZSs
HSIU1
Capex coverage ratio
98
Gg5RT
Fn2cX
Free cash flow margin
58
xnZO0
rfktt
Return on invested capital
65
nCdbz
pCu3W
Return on equity
64
eW45H
mcNt5
Return on assets
65
oAsVM
YlyeH
Capex / Revenue
76
cF9Ro
hG7o8
Profitable years 5Y
71
on17f
3MtNk
Value
Rating
SMA 50 vs Price
21
uZPcy
LyOqK
SMA 200 vs Price
3
1EN5E
sEtxJ
SMA 50 vs SMA 200
7
2GTd6
H6P03
1M Decile rank
41
jZrZD
95Rn0
6M Decile rank
27
27gyt
N3jjD
1Y Decile rank
91
p8XsX
qyWCp
